profit from every $100 of sales.
$0$100
Jade Biosciences
$16.14+1.70% today
+27.6% in 1 year
1-year low $11.481-year high $26.85
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Jade Biosciences vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Jade Biosciences | No profit yet | ||
 Vertex Pharmaceuticals | 34.5× · Expensive | ||
 Regeneron Pharmaceuticals | 21.9× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.0× · Fair price |
AI analysis
An AI analyst reads Jade Biosciences's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2025 |
|---|---|
| 0 | |
| – | |
| -114 | |
| -114 | |
| -127 | |
| -3.19 | |
| – | |
| – | |
| – |
Balance sheet
| In millions of USD | 2025 |
|---|---|
| Total assets | 350 |
| Cash | 88 |
| Total debt | 1 |
| Total liabilities | 17 |
| 333 | |
| 31 | |
| -26.9% | |
| -38.3% |
Cash flow
| In millions of USD | 2025 |
|---|---|
| -95 | |
| 0 | |
| -95 | |
| Dividends paid | – |
| – | |
| 20 |
Valuation
- –
- –
- –
- 4.6×
- –
- –
- –
- -9.2%
- -12.4%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -45.0%
- -50.2%
- -51.3%
- -40.6%
- -45.0%
- –
Growth
- –
- –
- −33.3%
- –
- +159.0%
Financial health
- 0.4×
- 0.00
- 0.2%
- –
- 14.29
- 14.29
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 8%of 952
Bottom 20%of 884
Bottom 11%of 987
What analysts expect
- Average price target
- $42.50
- Range
- $40.00 – $45.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | -0.57 | -0.52 | −9.6% |
| Mar 6, 2026 | -0.11 | -0.45 | +75.6% |
| Nov 13, 2025 | -0.48 | -0.57 | +15.8% |
| Aug 13, 2025 | -0.86 | -0.43 | −100.0% |
| Apr 25, 2025 | -0.09 | -8.40 | +98.9% |
| Mar 27, 2025 | -0.19 | -0.19 | +0.0% |
News
Meta's legal troubles has options traders eyeing the 'jade lizard'CNBC · Aug 19, 2026The newest story we have is from Aug 19, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
22No pass
Benjamin Graham
40No pass
Philip Fisher
37No pass
Peter Lynch
60Pass
Joel Greenblatt
0No pass
Charlie Munger
30No pass
Terry Smith
27No pass
Questions about Jade Biosciences
Is Jade Biosciences a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Jade Biosciences AI analysis
What does Jade Biosciences do?
Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. It is in Biotechnology.
Does Jade Biosciences pay a dividend?
No. Jade Biosciences does not pay a dividend at the moment.
Is Jade Biosciences stock halal?
Questionable. Jade Biosciences sits in a grey zone: short-term investments may earn interest; type not reported. How we check
How has Jade Biosciences stock done over the past year?
Up 27.6% over the past twelve months, to $16.14. It traded between $11.48 and $26.85 and is 39.9% below its high.
Who are Jade Biosciences's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with Jade Biosciences's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.